This federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp, the prime contractor. The contract has a ceiling value of $3,153.90 and is a firm fixed-price delivery order. It has an ultimate completion date of August 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to supply the DLA, a defense agency, with the specified medication. This award is part of a...
This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The contract has an award value of $9,142.92 and a completion date of September 20, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a prescription pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,975.72 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 16, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award is for the provision of ADVAIR HFA 230-21 MCG INHALER 12GM pharmaceuticals to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $26,320.17 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 17, 2024 and does not have a set-aside designation, indicating open competition....
The federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has an award value of $8,649.08 and a completion date of February 28, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The contract has a ceiling value of $7,704.66 and runs through January 24, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract is a delivery order and uses a firm fixed price pricing type. The contract was awarded on January 23, 2024 and has no set-aside designation, indicating...
This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,713.26 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA). The $9,590.46 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 24, 2024 with a completion date of July 25, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a primary vehicle for providing...
The federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,144.60, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price, and the ultimate completion date is set for April 22, 2024. The contract does not have a set-aside designation, indicating open...
This federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $7,786.66 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a completion date of February 14, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug...